Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth
Civmec has delivered FY26 revenue growth of 11.4% and a 22.5% rise in profit, with a $1.4 billion order book supporting its FY27 outlook.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| BLT | Nasdaq today | 24/04/18 | 15 | 2.6K | |||
|
|||||||
| BLT | Ann: CORPORATE PRESENTATION | 24/04/18 | 0 | 100 | |||
|
|||||||
| BLT | Ann: CLINICAL PROGRAM UPDATE | 24/04/18 | 0 | 134 | |||
|
|||||||
| BLT | DIRK Blog | 24/04/18 | 0 | 150 | |||
|
|||||||
| BLT | A Future Without Death-Celularity CEO | 24/04/18 | 0 | 131 | |||
|
|||||||
| BLT | Gene Therapy | 20/04/18 | 5 | 1.5K | |||
|
|||||||
| BLT | Falling behind again? | 19/04/18 | 1 | 366 | |||
|
|||||||
| BLT | Cancer | 16/04/18 | 25 | 6.5K | |||
|
|||||||
See All Discussions
ASX News